SGM
KMTS

Seven Grand Managers’s Kestra Medical Technologies KMTS Stock Holding History

Seven Grand Managers’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.99M Hold
100,000
– – 0.13% 116
2025
Q4 		$2.65M Buy
+100,000
New +$2.58M 0.2% 100

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Seven Grand Managers's KMTS Position: Q1 2026 in Review

Seven Grand Managers held its Kestra Medical Technologies (KMTS) position steady in Q1 2026 at 100,000 shares worth $1.99M. The position accounts for 0.13% of the portfolio, ranked #116.

Seven Grand Managers first reported a position in KMTS in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.65M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Seven Grand Managers held 100,000 shares of Kestra Medical Technologies worth $1.99M as of Q1 2026.
  • Seven Grand Managers left its Kestra Medical Technologies share count unchanged in Q1 2026.
  • Kestra Medical Technologies made up 0.13% of Seven Grand Managers's portfolio in Q1 2026, its #116 holding.
  • Seven Grand Managers first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 2 quarters since.
  • Seven Grand Managers's Kestra Medical Technologies position peaked at $2.65M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Seven Grand Managers's 13F filing for Q1 2026, filed 6 May 2026.